JPS5943942B2 - タウリン誘導体 - Google Patents

タウリン誘導体

Info

Publication number: JPS5943942B2
Authority: JP; Japan
Prior art keywords: formula; taurine; compound; formulas; tables
Prior art date: 1978-06-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

JP54075148A

Other languages

English (en)

Japanese (ja)

Other versions

JPS554381A (en

Inventor

ラフアエル・パソニ

ビツトリオ・カンボニ

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

RABORATORIO KIMIKO FUARUMASEEUCHIKO KAUSHISU SpA

Original Assignee

RABORATORIO KIMIKO FUARUMASEEUCHIKO KAUSHISU SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-06-15

Filing date

1979-06-13

Publication date

1984-10-25

1979-06-13 Application filed by RABORATORIO KIMIKO FUARUMASEEUCHIKO KAUSHISU SpA filed Critical RABORATORIO KIMIKO FUARUMASEEUCHIKO KAUSHISU SpA

1980-01-12 Publication of JPS554381A publication Critical patent/JPS554381A/ja

1984-10-25 Publication of JPS5943942B2 publication Critical patent/JPS5943942B2/ja

Status Expired legal-status Critical Current

Links

XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title claims description 6
SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical class COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 claims description 3
239000000126 substance Substances 0.000 claims 4
125000003545 alkoxy group Chemical group 0.000 claims 1
125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims 1
125000005843 halogen group Chemical group 0.000 claims 1
238000004519 manufacturing process Methods 0.000 claims 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
150000001875 compounds Chemical class 0.000 description 16
239000000047 product Substances 0.000 description 11
241001465754 Metazoa Species 0.000 description 9
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
239000000243 solution Substances 0.000 description 7
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
235000019441 ethanol Nutrition 0.000 description 6
229960003080 taurine Drugs 0.000 description 6
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
235000005911 diet Nutrition 0.000 description 5
230000037213 diet Effects 0.000 description 5
238000002844 melting Methods 0.000 description 5
230000008018 melting Effects 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
239000000706 filtrate Substances 0.000 description 4
241000700159 Rattus Species 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
238000000034 method Methods 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
238000003756 stirring Methods 0.000 description 3
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
230000010933 acylation Effects 0.000 description 2
238000005917 acylation reaction Methods 0.000 description 2
210000000941 bile Anatomy 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
231100000572 poisoning Toxicity 0.000 description 2
230000000607 poisoning effect Effects 0.000 description 2
238000001953 recrystallisation Methods 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000028327 secretion Effects 0.000 description 2
SGSMPWTZYGTIEA-UHFFFAOYSA-N 2-(ethylamino)ethanesulfonic acid Chemical compound CCNCCS(O)(=O)=O SGSMPWTZYGTIEA-UHFFFAOYSA-N 0.000 description 1
IWPZKOJSYQZABD-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Natural products COC1=CC(OC)=CC(C(O)=O)=C1 IWPZKOJSYQZABD-UHFFFAOYSA-N 0.000 description 1
BUHYMJLFRZAFBF-UHFFFAOYSA-N 3,4,5-trimethoxybenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC BUHYMJLFRZAFBF-UHFFFAOYSA-N 0.000 description 1
-1 3,4,5-trimethoxybenzoyl chloride hydrochloride Chemical compound 0.000 description 1
OTTPFCJTQXRWHO-UHFFFAOYSA-N 3-(2,3-dichloroanilino)cyclohex-2-en-1-one Chemical class ClC1=CC=CC(NC=2CCCC(=O)C=2)=C1Cl OTTPFCJTQXRWHO-UHFFFAOYSA-N 0.000 description 1
OKIBNKKYNPBDRS-UHFFFAOYSA-N Mefluidide Chemical compound CC(=O)NC1=CC(NS(=O)(=O)C(F)(F)F)=C(C)C=C1C OKIBNKKYNPBDRS-UHFFFAOYSA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
235000002597 Solanum melongena Nutrition 0.000 description 1
244000061458 Solanum melongena Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
230000002402 anti-lipaemic effect Effects 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
229910001863 barium hydroxide Inorganic materials 0.000 description 1
VJLOFJZWUDZJBX-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;chloride Chemical compound [Cl-].OCC[NH2+]CCO VJLOFJZWUDZJBX-UHFFFAOYSA-N 0.000 description 1
238000009835 boiling Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
231100000517 death Toxicity 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
230000000694 effects Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
KIWQWJKWBHZMDT-UHFFFAOYSA-N homocysteine thiolactone Chemical compound NC1CCSC1=O KIWQWJKWBHZMDT-UHFFFAOYSA-N 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
239000000155 melt Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
DAKAQNVUSAGTRS-UHFFFAOYSA-M sodium;1-bromoethanesulfonate Chemical compound [Na+].CC(Br)S([O-])(=O)=O DAKAQNVUSAGTRS-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000004584 weight gain Effects 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

JP54075148A 1978-06-15 1979-06-13 タウリン誘導体 Expired JPS5943942B2 (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT24587/78A IT1096662B (it)	1978-06-15	1978-06-15	Derivati taurinici ad attivita'antilipemica e coleretica,processo per la loro preparazione e composizioni farmaceutiche che li contengono
IT0024587-A/78		1978-06-15

Publications (2)

Publication Number	Publication Date
JPS554381A JPS554381A (en)	1980-01-12
JPS5943942B2 true JPS5943942B2 (ja)	1984-10-25

Family

ID=11214073

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP54075148A Expired JPS5943942B2 (ja)	1978-06-15	1979-06-13	タウリン誘導体
JP23774083A Pending JPS6133171A (ja)	1978-06-15	1983-12-16	タウリン誘導体

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP23774083A Pending JPS6133171A (ja)	1978-06-15	1983-12-16	タウリン誘導体

Country Status (9)

Country	Link
JP (2)	JPS5943942B2 (fr)
BE (1)	BE876969A (fr)
DE (1)	DE2901046C3 (fr)
ES (3)	ES476812A1 (fr)
FR (2)	FR2465717A1 (fr)
GB (1)	GB2023586B (fr)
IT (1)	IT1096662B (fr)
LU (1)	LU81379A1 (fr)
NL (1)	NL7904644A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1126575B (it) *	1979-12-07	1986-05-21	Causyth Chim Farm	Composto ad attivita' antiinfiammatoria,analgesica e antipiretica,processo per la sua preparazione,e relative composizioni farmaceutiche

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR920312A (fr) *	1944-08-01	1947-04-03	Ward	Procédé de préparation de dérivés de l'acide nicotique
GB586453A (en) *	1944-08-01	1947-03-19	Ward Blenkinsop & Co Ltd	Process for the production of derivatives of nicotinic acid
CH520697A (fr) *	1970-03-03	1972-03-31	Sopharma Sa	Procédé de préparation d'un ester-amide de l'acide nicotinique

1978
- 1978-06-15 IT IT24587/78A patent/IT1096662B/it active
1979
- 1979-01-11 FR FR7900641A patent/FR2465717A1/fr active Pending
- 1979-01-12 DE DE2901046A patent/DE2901046C3/de not_active Expired
- 1979-01-12 ES ES476812A patent/ES476812A1/es not_active Expired
- 1979-06-13 NL NL7904644A patent/NL7904644A/xx not_active Application Discontinuation
- 1979-06-13 JP JP54075148A patent/JPS5943942B2/ja not_active Expired
- 1979-06-14 BE BE2/57867A patent/BE876969A/xx not_active IP Right Cessation
- 1979-06-14 LU LU81379A patent/LU81379A1/fr unknown
- 1979-06-15 GB GB7920953A patent/GB2023586B/en not_active Expired
- 1979-07-13 ES ES482484A patent/ES482484A1/es not_active Expired
- 1979-07-13 ES ES482483A patent/ES482483A1/es not_active Expired
1982
- 1982-08-11 FR FR8214014A patent/FR2511365A1/fr active Granted
1983
- 1983-12-16 JP JP23774083A patent/JPS6133171A/ja active Pending

Also Published As

Publication number	Publication date
LU81379A1 (fr)	1979-09-12
IT7824587A0 (it)	1978-06-15
ES482484A1 (es)	1980-04-01
BE876969A (nl)	1979-10-01
FR2465717A1 (fr)	1981-03-27
FR2511365B1 (fr)	1985-03-15
FR2511365A1 (fr)	1983-02-18
ES476812A1 (es)	1979-12-16
GB2023586B (en)	1982-08-04
DE2901046B2 (de)	1981-07-16
IT1096662B (it)	1985-08-26
NL7904644A (nl)	1979-12-18
GB2023586A (en)	1980-01-03
JPS6133171A (ja)	1986-02-17
DE2901046C3 (de)	1982-05-06
JPS554381A (en)	1980-01-12
DE2901046A1 (de)	1979-12-20
ES482483A1 (es)	1980-04-16

Publication	Publication Date	Title
US4128651A (en)	1978-12-05	Bis-quaternary pyridinium-2-aldoxime salts and a process for their preparation
US3862152A (en)	1975-01-21	3-carbamoylamino-4-phenyl quinoline compounds
GB1568398A (en)	1980-05-29	Triazolo pyridazine derivatives
EP0233760B1 (fr)	1991-05-15	Dérivés de sulfénamide et leur production
JPS5943942B2 (ja)	1984-10-25	タウリン誘導体
US4115394A (en)	1978-09-19	Amino derivatives of 6-phenylpyrazolo[3,4-b]pyridines
JPH03190872A (ja)	1991-08-20	新規なチオフェン誘導体
US3900486A (en)	1975-08-19	3-methyl-2-phenyl-5-benzothiazoline acetic acid compounds and process for producing the same
US4055650A (en)	1977-10-25	Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
JPS6019748B2 (ja)	1985-05-17	イソインドリン誘導体の製法
JPS5849369A (ja)	1983-03-23	新規のイミダゾール化合物
CA1051895A (fr)	1979-04-03	Derives d'acide 1h-triazolo(4,5-c)pyridine carboxylique-7 et de ses esters
US3478028A (en)	1969-11-11	4-substituted-1-hydroxylaminophthalazines
US3426017A (en)	1969-02-04	Sulfonylurea compounds
US3432502A (en)	1969-03-11	Preparation of pyrazinoylguanidine and pyrazinamidoguanidine products
CA1089855A (fr)	1980-11-18	Derives de pyrazolo [1,5-a] pyrido [2,3-d]- pyrimidin-9(4h)-one
US4075210A (en)	1978-02-21	Pyrazolo[1,5-a]pyrido[4,3-d]pyrimidin-9(4H)-one and derivatives thereof
US3711505A (en)	1973-01-16	2-(2-imidazolin-2-ylthio)-acetanilides
US3576809A (en)	1971-04-27	2-substituted derivatives of 6-methoxyquinoline
EP0027957A1 (fr)	1981-05-06	Amino-2 (benzyloxy-4 phényl)-4 thiazoles, leur préparation et compositions pharmaceutiques les contenant
JPS58148858A (ja)	1983-09-05	３，５−ジ−ｔｅｒｔ−ブチル−４−ヒドロキシフエニル置換複素環化合物
US4697013A (en)	1987-09-29	Condensed as-triazine derivatives
US2748120A (en)	1956-05-29	2-amino-6-aryl-5, 6-dihydro-4-hydroxy-pyrimidines
US3201475A (en)	1965-08-17	Bisglyoxalyldiphenyl derivatives
CA1056398A (fr)	1979-06-12	Derives de la 1-hydroxybenzo-2,3,1-diazaborine et procede pour leur preparation